Optimize Your Visibility

ZEISS presents our newest VersaXRM® 730 3D X-ray microscope.

RegSmart Life Science AB

Italian pharmaceutical company buys rights to immunotherapy from Sanofi

Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).

Aurevia

WuXi AppTec, UK Ltd

A small thing that can solve your problems

If you are in need of a compact valve. Look no further! We have the VOVK

Medicon Valley Alliance

Mercodia AB

Galderma

Truly Labs AB

SGS Fimko Ltd.

JMP Statistical Discovery

QPS Netherlands B.V

Are you ready for EMC 2024?

Visit ZEISS at Europe’s largest Event dedicated to Microscopy and Imaging.

ProPharma

Medeon AB

Clinigen Clinical Supplies Management GmbH

CTC Clinical Trial Consultants AB

TECHNIA AB

Cytel Sweden

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.

Thumbs down for lecanemab in the EU – “Very surprised”

The Azheimer's drug lecanemab has received a negative assessment from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), acc...

Zelmic

A+ Science AB